These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38479593)

  • 1. Evaluation of the translation of multiple cardiovascular regulatory mechanisms in the anesthetized dog.
    Antic O; Koshman YE; Bird BM; Jasiek G; Wilsey AS; Mittelstadt SW; Foley CM
    J Pharmacol Toxicol Methods; 2024; 126():107497. PubMed ID: 38479593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of drug-induced changes in left ventricular function in pentobarbital-anesthetized dogs.
    Koshman YE; Herzberg BR; Seifert TR; Polakowski JS; Mittelstadt SW
    J Pharmacol Toxicol Methods; 2018; 91():27-35. PubMed ID: 29330133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the utility of LVdP/dt
    Pugsley MK; Guth B; Chiang AY; Doyle JM; Engwall M; Guillon JM; Hoffmann PK; Koerner JE; Mittelstadt SW; Pierson JB; Rossman EI; Sarazan DR; Parish ST
    J Pharmacol Toxicol Methods; 2017; 85():1-21. PubMed ID: 28065821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced QT prolongation: Concordance of preclinical anesthetized canine model in relation to published clinical observations for ten CiPA drugs.
    Koshman YE; Wilsey AS; Bird BM; Endemann AL; Sadilek S; Treadway J; Martin RL; Polakowski JS; Gintant GA; Mittelstadt SW
    J Pharmacol Toxicol Methods; 2020; 103():106871. PubMed ID: 32360993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxypropyl-β-cyclodextrin impacts renal and systemic hemodynamics in the anesthetized dog.
    Rosseels ML; Delaunois AG; Hanon E; Guillaume PJ; Martin FD; van den Dobbelsteen DJ
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):351-9. PubMed ID: 23978386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortium.
    Guth BD; Chiang AY; Doyle J; Engwall MJ; Guillon JM; Hoffmann P; Koerner J; Mittelstadt S; Ottinger S; Pierson JB; Pugsley MK; Rossman EI; Walisser J; Sarazan RD
    J Pharmacol Toxicol Methods; 2015; 75():70-90. PubMed ID: 25843226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development.
    Caruso A; Frances N; Meille C; Greiter-Wilke A; Hillebrecht A; Lavé T
    J Pharmacol Toxicol Methods; 2014; 70(1):73-85. PubMed ID: 24879942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Associations Between Nonclinical Cardiovascular Functional Endpoints and Repeat-dose Cardiovascular Toxicity in the Beagle Dog: A Cross-company Initiative.
    Milliken P; Aylott M; Edmunds N; Engle S; Ewart L; Fleurance R; Guffroy M; Hargreaves A; Heinz-Taheny K; Kirk S; Leishman D; Leong L; McMahon N; Valentin JP; Watson D; Wallis R; Clements P
    Toxicol Sci; 2020 Jul; 176(1):224-235. PubMed ID: 32298455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test of the usefulness of a paradigm to identify potential cardiovascular liabilities of four test articles with varying pharmacological properties in anesthetized guinea pigs.
    Kijtawornrat A; Ueyama Y; del Rio C; Sawangkoon S; Buranakarl C; Chaiyabutr N; Hamlin RL
    Toxicol Sci; 2014 Feb; 137(2):458-68. PubMed ID: 24189130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disconnect between COX-2 selective inhibition and cardiovascular risk in preclinical models.
    Koshman YE; Bielinski AL; Bird BM; Green JR; Kowalkowski KL; Lai-Zhang J; Mahalingaiah PK; Sawicki JW; Talaty NN; Wilsey AS; Zafiratos MT; Van Vleet TR
    J Pharmacol Toxicol Methods; 2023; 120():107251. PubMed ID: 36792039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel intravenous vehicle for preclinical cardiovascular screening of small molecule drug candidates in rat.
    Banfor PN; Gintant GA; Lipari JM; Zocharski PD
    J Pharmacol Toxicol Methods; 2016; 82():62-67. PubMed ID: 27432021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tutorial for model-based evaluation and translation of cardiovascular safety in preclinical trials.
    Kulesh V; Vasyutin I; Volkova A; Peskov K; Kimko H; Sokolov V; Alluri R
    CPT Pharmacometrics Syst Pharmacol; 2024 Jan; 13(1):5-22. PubMed ID: 37950388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical to Clinical Translation of Hemodynamic Effects in Cardiovascular Safety Pharmacology Studies.
    Bhatt S; Northcott C; Wisialowski T; Li D; Steidl-Nichols J
    Toxicol Sci; 2019 May; 169(1):272-279. PubMed ID: 30726989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of recombinant human brain natriuretic peptide and milrinone on cardiac hemodynamics and renal function in anesthetized dog].
    Xu XW; Yang W; Zhao ZY; Liu HX; Zeng GY
    Yao Xue Xue Bao; 2002 Jul; 37(7):506-9. PubMed ID: 12914318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical cardiovascular safety assessment of pharmacology-toxicology relationship for a set of novel kinase inhibitors.
    Koshman YE; Kohnken R; Logan MR; Mittelstadt SW; Foley CM
    Toxicol Sci; 2024 Mar; 198(2):316-327. PubMed ID: 38191231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs.
    Kågström J; Sjögren EL; Ericson AC
    J Pharmacol Toxicol Methods; 2007; 56(2):186-93. PubMed ID: 17582787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of torcetrapib in conscious and pentobarbital-anesthetized dogs.
    Polakowski JS; King AJ; Campbell TJ; Nelson RA; Preusser LC; Kempf-Grote AJ; Marsh KC; Gintant GA; Cox BF; Mittelstadt SW
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):543-51. PubMed ID: 19770671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergisms of cardiovascular effects between iptakalim and amlodipine, hydrochlorothiazide or propranolol in anesthetized rats.
    Zhou HM; Zhong ML; Wang RH; Long CL; Zhang YF; Cui WY; Wang H
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Nov; 31(6):532-40. PubMed ID: 27215021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of housing conditions on baseline cardiovascular parameters and the sensitivity to detect changes in contractility in telemetry-implanted dogs.
    Sadekova N; Boudreau G; Jalbert B; Norton K
    J Pharmacol Toxicol Methods; 2016; 81():60-74. PubMed ID: 27163176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins.
    Koshman YE; Wilsey AS; Bird BM; Sadilek S; Weisbecker DA; Ebert PA; Polakowski JS; Gintant GA; Mittelstadt SW; Foley CM
    J Pharmacol Toxicol Methods; 2021; 111():107109. PubMed ID: 34416395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.